Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain games may fight chemo brain fog in breast cancer patients

NCT ID NCT07165912

Not yet recruiting Symptom relief Sponsor: University of Salamanca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a personalized cognitive training program can reduce 'chemobrain' in breast cancer patients receiving chemotherapy. 75 women will be split into two groups: one gets the training plus a healthy lifestyle leaflet, the other gets only the leaflet. Researchers will measure thinking skills, memory, and quality of life after 4 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cognitive training program
What this could lead to
If it works, this could point toward a simple, non-drug way to help breast cancer patients think more clearly during chemotherapy.
What could go wrong
This is a small, early-stage trial with only 75 participants. The cognitive training is self-guided, so results may vary, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer female breast carcinoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FEMALES ONCOLOGY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Juan Luis

    Salamanca, Salamanca, 37004, Spain

  • Juan Luis

    Salamanca, Salamanca, 37004, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.